- 24/7 Technology,Internet,Bio Patent and Intellectual Property News & Information Service
-
SUBSCRIBE TO FEED
- Who are patent attorneys?
- What are patents, and how long are they in force?
- Valuing patents
- Steps in the Patent Process
- Intellectual Property and patents thereof
- History of Patents and Patent Law
- Copyrights & Copyright Law History
- Historically Famous U.S. patents
- Comparing Patents & Copyrights
- Applying for a Patent? Follow these steps
-
Articles
'Clinical' Tag
-
Poniard Pharmaceuticals picoplatin Phase 2 study in metastatic CRPC: Positive results
March 6, 2010[Story ID: 711]
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company’s Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster [...] -
Healthcare leaders convene to discuss patient safety at global summit
February 18, 2010[Story ID: 405]
Hospital executives and global health care leaders will gather in Nice, France on April 20 for a summit to address the clinical, operational and financial returns of investing in patient safety. -
Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal
February 17, 2010[Story ID: 394]
BG Medicine, Inc. announced today that the results of a controlled study on the utility of its galectin-3 test in heart failure were published in the Journal Clinical Research in Cardiology, a peer-reviewed, international journal that publishes original research and review articles on clinical research studies in the field of cardiology. -
Ragweed pollen allergy: SLIT safe and effective alternative to injections
February 15, 2010[Story ID: 354]
An oral allergy treatment administered in drops under the tongue is a safe and effective alternative to injections for adults who are allergic to ragweed pollen, according to a study published today in the Journal of Allergy and Clinical Immunology by allergic disease specialist at Allegheny General Hospital. -
Diabetic retinopathy: 5.3M U.S adults suffer
February 12, 2010[Story ID: 342]
Despite major progress in diagnosis and treatment, diabetic retinopathy remains the major cause of blindness in adults under 60 in the U.S., said Thomas C. Lee, director, Retina Institute in The Vision Center at Childrens Hospital Los Angeles, associate professor of clinical ophthalmology at the Keck School of Medicine of the University of [...] -
Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented
February 12, 2010[Story ID: 340]
Protalix BioTherapeutics, Inc., announced today that additional data from the Company’s pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, “Novel Enzyme Replacement Therapy for Gaucher Disease: [...] -
FDAs issues guidance on Bayesian statistical methods in medical device clinical trials
February 6, 2010[Story ID: 235]
The U.S. Food and Drug Administration today issued guidance on Bayesian statistical methods in the design and analysis of medical device clinical trials that could result in less costly and more efficient patient studies. -
Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients
February 5, 2010[Story ID: 219]
Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart’ -
Aurora St. Lukes Medical Center honored with Distinguished Hospital Award for Clinical Excellence
January 30, 2010[Story ID: 111]
Aurora St. Luke’s Medical Center has been identified by HealthGrades as a 2010 recipient of the Distinguished Hospital Award for Clinical Excellence. HealthGrades awards this title to facilities that rank in the top five percent in overall clinical performance.